Stichting Amsterdam UMC
Stichting Amsterdam UMC is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
HOVON 172 MF: A phase 1b/2 trial with tasquinimod in patients with myelofibrosis (primary, post-PV or post-ET) refractory to or intolerant for JAK2 inhibition: the TasqForce trial
Sponsor Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II study of iberdomide (CC220) maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients
Sponsor European Myeloma Network B.V.
- Start (EU)
- Latest update
- Estimated end
- Not reported
GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)
Sponsor Stichting Amsterdam UMC
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Stichting Amsterdam UMC?
The 2026-10-09 snapshot links Stichting Amsterdam UMC to 3 distinct CTIS trials. Recorded services include Laboratory services, For substudy: flow cytometry, Pathology and Imaging review. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Stichting Amsterdam UMC?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Stichting Amsterdam UMC conducted?
The linked trials record locations in 5 countries, including Netherlands, Germany, France, Greece, Italy. These are trial locations, not confirmed office locations or countries where Stichting Amsterdam UMC delivered services.
What can this page tell me about Stichting Amsterdam UMC's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Stichting Amsterdam UMC. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Stichting Amsterdam UMC